Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12055240rdf:typepubmed:Citationlld:pubmed
pubmed-article:12055240lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0441471lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1332700lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1332690lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1332691lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C1579373lld:lifeskim
pubmed-article:12055240lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12055240pubmed:issue12lld:pubmed
pubmed-article:12055240pubmed:dateCreated2002-6-10lld:pubmed
pubmed-article:12055240pubmed:abstractTextHuman memory CD4(+) T cells respond better to inflammatory CCLs/CC chemokines, CCL3 and CCL5, than naive CD4(+) T cells. We analyzed the regulatory mechanism underlying this difference. Memory and naive CD4(+) T cells expressed similarly high levels of CCR1; however, CCR5 was only expressed in memory CD4(+) T cells at low levels. Experiments using mAbs to block chemokine receptors revealed that CCR1 functioned as a major receptor for the binding of CCL5 in memory and naive CD4(+) T cells as well as the ligand-induced chemotaxis in memory CD4(+) T cells. Stimulation of memory CD4(+) T cells with CCL5 activated protein tyrosine kinase-dependent cascades, which were significantly blocked by anti-CCR1 mAb, whereas this stimulation failed to induce these events in naive CD4(+) T cells. Intracellular expressions of regulator of G protein signaling 3 and 4 were only detected in naive CD4(+) T cells. Pretreatment of cell membrane fractions from memory and naive CD4(+) T cells with GTP-gamma S inhibited CCL5 binding, indicating the involvement of G proteins in the interaction of CCL5 and its receptor(s). In contrast, CCL5 enhanced the GTP binding to G(i alpha) and G(q alpha) in memory CD4(+) T cells, but not in naive CD4(+) T cells. Thus, a failure of the ligand-induced activation of CCR1-mediated downstream signaling event as well as a deficiency of CCR5 expression may be involved in the hyporesponsiveness of naive CD4(+) T cells to CCL3 and CCL5.lld:pubmed
pubmed-article:12055240pubmed:languageenglld:pubmed
pubmed-article:12055240pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12055240pubmed:statusMEDLINElld:pubmed
pubmed-article:12055240pubmed:monthJunlld:pubmed
pubmed-article:12055240pubmed:issn0022-1767lld:pubmed
pubmed-article:12055240pubmed:authorpubmed-author:MorimotoChika...lld:pubmed
pubmed-article:12055240pubmed:authorpubmed-author:KawasakiHiros...lld:pubmed
pubmed-article:12055240pubmed:authorpubmed-author:SatoKatsuakiKlld:pubmed
pubmed-article:12055240pubmed:authorpubmed-author:YamashimaNaoh...lld:pubmed
pubmed-article:12055240pubmed:authorpubmed-author:MatsuyamaTaka...lld:pubmed
pubmed-article:12055240pubmed:issnTypePrintlld:pubmed
pubmed-article:12055240pubmed:day15lld:pubmed
pubmed-article:12055240pubmed:volume168lld:pubmed
pubmed-article:12055240pubmed:ownerNLMlld:pubmed
pubmed-article:12055240pubmed:authorsCompleteYlld:pubmed
pubmed-article:12055240pubmed:pagination6263-72lld:pubmed
pubmed-article:12055240pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:meshHeadingpubmed-meshheading:12055240...lld:pubmed
pubmed-article:12055240pubmed:year2002lld:pubmed
pubmed-article:12055240pubmed:articleTitleAn abortive ligand-induced activation of CCR1-mediated downstream signaling event and a deficiency of CCR5 expression are associated with the hyporesponsiveness of human naive CD4+ T cells to CCL3 and CCL5.lld:pubmed
pubmed-article:12055240pubmed:affiliationDepartment of Immunology and Medical Zoology, School of Medicine, Kagoshima University, Sakuragaoka, Kagoshima, Japan. katusaki@m3.kufm.kagoshima-u.ac.jplld:pubmed
pubmed-article:12055240pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12055240pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12055240pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12055240lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12055240lld:pubmed